A nutritional role is not proof of antiviral treatment
Adequate nutrition supports health, but that does not establish a supplement’s ability to control herpes simplex outbreaks. A general immune-support claim is different from evidence for healing time, recurrence frequency or transmission. Product claims should identify which outcome was actually studied. [1][2]
Lysine remains uncertain
The inspected review found no convincing evidence that lysine treats active herpes simplex lesions and considered prevention evidence insufficient. Older studies used varied regimens and reached different conclusions. An in-vitro lysine-arginine mechanism does not identify a reliable self-treatment dose. [3]
Genital herpes has established antiviral options
CDC describes acyclovir, valacyclovir and famciclovir for relevant clinical situations, including episodic treatment and daily suppression. These medicines can control symptoms and reduce recurrences but do not eradicate latent infection. Selection and dosing depend on the clinical context. [2]
Cold sores and genital infection require different practical advice
NHS provides cold-sore guidance on early treatment, avoiding transmission and seeking care for concerning cases. CDC emphasizes diagnosis, counseling and pregnancy-related risks for genital herpes. Do not apply a cold-sore supplement anecdote to a newborn exposure, eye problem or severe genital episode. [4][2]
Judge a proposed add-on against the right outcome
Imagine someone has fewer outbreaks for a month after starting several supplements. Natural fluctuation and other changes make that observation difficult to interpret. Discuss recurrent episodes and established prevention options rather than assume that the supplement cleared the virus. [3][2]
| Claim | Important distinction |
|---|---|
| Immune support | Not proof of HSV control |
| Lysine prevention | Insufficient evidence for a dependable regimen |
| Faster healing | Different from fewer recurrences |
| Antiviral suppression | Controls infection without eradicating latency |
Sources for this article
- Dietary Supplements: What You Need to Know
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Herpes - STI Treatment Guidelines
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence - PMC
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Cold sores - NHS
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.